WallStSmart
BOLD

Boundless Bio, Inc. Common Stock

NASDAQ: BOLD · HEALTHCARE · BIOTECHNOLOGY

$1.46
+0.69% today

Updated 2026-04-30

Market cap
$33.61M
P/E ratio
P/S ratio
EPS (TTM)
$-2.60
Dividend yield
52W range
$1 – $2
Volume
0.2M

Boundless Bio, Inc. Common Stock (BOLD) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+73.5%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+21.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-3.1%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-26$-0.58+50.0%$1.13$1.11-1.8%
2025-11-05$-0.62+43.1%$1.30$1.26-3.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.16$-0.58+50.0%
2025-09-30$-1.09$-0.62+43.1%
2025-06-30$-1.02$-0.70+31.4%
2025-03-31$-1.02$0.71+169.6%
2024-12-31$-0.84$-0.74+11.9%$1.06M
2024-09-30$-0.73$-0.74-1.4%
2024-06-30$-0.65$-0.77-18.5%
2024-03-31$-0.55$-12.27-2130.9%
2023-12-31$0.00$-9.76
2019-09-30$-1.07$-1.00+6.5%
2019-06-30$-1.04$-1.01+2.9%
2019-03-31$-0.89$-1.13-27.0%
2018-12-31$-0.91$-0.84+7.7%

Frequently asked questions

Has Boundless Bio, Inc. Common Stock beaten earnings estimates?
Boundless Bio, Inc. Common Stock has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +73.5% over the last 4 quarters.
How does BOLD stock react to earnings?
BOLD stock has moved an average of -2.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.